Accrued Expenses and Other Current Liabilities (Tables)

12 Months Ended

Dec. 31, 2022

Payables and Accruals [Abstract]

Schedule of Accrued Expenses and Other Current Liabilities

Accrued expenses and other current liabilities consist of the following (in thousands):

	December 31,
	2022		2021
Accrued payments due to AstraZeneca	$	3,385	$	69
Accrued gross to net revenue liabilities	1,991		—
Accrued contract manufacturing expenses	1,657		2,485
Derivative liability for exit fees	1,656		698
Accrued non-clinical research and development expenses	1,188		265
Accrued professional and consulting services	808		597
Accrued sales and marketing expenses	587		256
Accrued clinical expenses	223		2,522
Other	885		474
Total accrued expenses and other current liabilities	$	12,380	$	7,366